New findings indicate HIV/AIDS pandemic began around 1900, earlier than previously thoughtOctober 02, 2008New research indicates that the most pervasive global strain of HIV began spreading among humans between 1884 and 1924, not during the 1930s, as previously reported. The earlier period of origin coincides with the establishment of urban centers in the west-central African region where the epidemic of this particular HIV strain-HIV-1 group M-emerged. This suggests that urbanization and associated high-risk behaviors set the stage for the HIV/AIDS pandemic. The research, led by Michael Worobey, D. Phil., of the University of Arizona in Tucson, was co-sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. To reach this earlier estimation of the origin of HIV, a team of scientists from four continents screened multiple tissue samples and uncovered the world's second-oldest genetic sequence of HIV-1 group M, which dates from 1960. The scientists then used it along with dozens of other previously known HIV-1 genetic sequences to construct a range of plausible family trees for this viral strain. The lengths of the tree branches represent the periods of time when the virus genetically diverged from its ancestors. The timing and number of these genetic mutations enabled the scientists to calibrate the probable range of rates at which the trees have grown-that is, the probable rates of evolution of HIV-1 group M. Based on this range of rates, the scientists projected back in time to the period when the trees most likely took root: around the turn of the 20th century. This marks the probable time of origin of HIV-1 group M, according to the researchers.
Using newly developed techniques, the scientists recovered the 48-year-old HIV gene fragments from a wax-embedded lymph-node tissue biopsy from a woman in Kinshasa in the Democratic Republic of the Congo. The oldest known HIV-1 group M genetic sequence comes from a 1959 blood sample from a man also from Kinshasa. A comparison of the same genetic region in the 1959 virus and the 1960 virus provided additional evidence that their common ancestor existed around 1900. The comparison revealed that the amount of genetic divergence between these two HIV sequences took more than 40 years to evolve. NIH/National Institute of Allergy and Infectious Diseases | |||||||||||||||||||||
|
Related AIDS Pandemic Current Events and AIDS Pandemic News Articles First Holistic Guide to Primate Disease Covers Critical Gap in Global Health Why are so many infectious diseases jumping from animals to humans? Why do we have so little capacity to predict epidemics, or avoid them? Results of landmark study of HIV vaccine published in the Lancet Results from the Step study, a test-of-concept efficacy study of a Merck & Co., Inc. HIV vaccine candidate, were published online today in two papers in The Lancet. These analyses of the Step study are being conducted, presented and published to inform the continued search for an effective HIV vaccine. Urbanization in Africa at dawn of 20th century marked outbreak of HIV New research indicates that the most pervasive global strain of HIV began spreading among humans between 1884 and 1924, suggesting that growing urbanization in colonial Africa set the stage for the HIV/AIDS pandemic. Why some primates, but not humans, can live with immunodeficiency viruses and not progress to AIDS Key differences in immune system signaling and the production of specific immune regulatory molecules may explain why some primates are able to live with an immunodeficiency virus infection without progressing to AIDS-like illness, unlike other primate species, including rhesus macaques and humans, that succumb to disease. Personalized immunotherapy to fight HIV/AIDS For a long time, the main obstacle to creating an AIDS vaccine has been the high genetic variability of the HIV virus. Dr. Jean-Pierre Routy and his team from the Research Institute of the McGill University Health Centre (MUHC), in collaboration with Dr. Rafick Sékaly from the Université de Montréal, have overcome this difficulty by designing a personalized immunotherapy for HIV-infected patients. Emerging infectious diseases on the rise: Next target 'hotspot' predicted It's not just your imagination. Providing the first-ever definitive proof, a team of scientists has shown that emerging infectious diseases such as HIV, Severe Acute Respiratory Syndrome (SARS), West Nile virus and Ebola are indeed on the rise. The release of new data from the HVTN 502 HIV vaccine study The new analyses revealed today from the STEP HIV vaccine clinical trial are both disappointing and puzzling. At this time, the data offer no clear explanations as to why the vaccine showed no measurable efficacy or why among individuals with background immunity to the adenovirus vector, there were more HIV infections in the vaccinees as compared to those in the placebo group. How Candida albicans transforms from its normally benign form into life-threatening form Researchers at the Agency for Science, Technology and Research's (A*STAR) Institute of Molecular and Cell Biology (IMCB) have discovered new molecular mechanisms that provide a more detailed understanding of how the normally benign Dr. Jekyll-like fungus known as Candida albicans transforms into a serious and often life-threatening Mr. Hyde-like form. Male circumcision overstated as prevention tool against AIDS In new academic research published today in the online, open-access, peer-reviewed scientific journal PLoS ONE, male circumcision is found to be much less important as a deterrent to the global AIDS pandemic than previously thought. Resistant HIV quickly hides in infants' cells New evidence shows that drug-resistant virus passed from mother-to-child can quickly establish itself in infants' CD4+ T cells where it can hide for years, likely limiting their options for future treatment. More AIDS Pandemic Current Events and AIDS Pandemic News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||